找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Cardiac Markers; Alan H. B. Wu Book 2003Latest edition Springer Science+Business Media New York 2003 Laboratory.Laboratory Medicine.Lipopr

[復(fù)制鏈接]
樓主: 滲漏
41#
發(fā)表于 2025-3-28 16:53:49 | 只看該作者
42#
發(fā)表于 2025-3-28 19:01:34 | 只看該作者
43#
發(fā)表于 2025-3-29 02:04:37 | 只看該作者
44#
發(fā)表于 2025-3-29 06:18:51 | 只看該作者
Nonuniformly Expanding Attractors,ns in patients with acute coronary syndromes (ACS) ., and a role in guiding antithrombotic therapy ., it is crucial that troponin assays have robust analytical performance to allow for reliable measurements, especially at low abnormal ranges.
45#
發(fā)表于 2025-3-29 09:23:57 | 只看該作者
46#
發(fā)表于 2025-3-29 15:03:01 | 只看該作者
Interferences in Immunoassays for Cardiac Troponinns in patients with acute coronary syndromes (ACS) ., and a role in guiding antithrombotic therapy ., it is crucial that troponin assays have robust analytical performance to allow for reliable measurements, especially at low abnormal ranges.
47#
發(fā)表于 2025-3-29 16:04:50 | 只看該作者
Nontraditional Security Concerns in Indiaed heart failure in children treated with the anthracycline daunorubicin, there has been an increased awareness of the potential for cardiovascular side effects during the course of cancer chemotherapy.
48#
發(fā)表于 2025-3-29 21:06:11 | 只看該作者
Nonunions: Treatment Objectives and Optionsspartate aminotransferase, CK and CK-MB, has gradually been replaced—although at different speeds in various countries—by automated quantitative immunoassays for mass determination of myoglobin, CK-MB, cardiac troponin I (cTnI), and cardiac troponin T (cTnT) ..
49#
發(fā)表于 2025-3-30 02:59:50 | 只看該作者
The Use of Cardiac Biomarkers to Detect Myocardial Damage Induced by Chemotherapeutic Agentsed heart failure in children treated with the anthracycline daunorubicin, there has been an increased awareness of the potential for cardiovascular side effects during the course of cancer chemotherapy.
50#
發(fā)表于 2025-3-30 04:04:53 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 18:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
南木林县| 四会市| 嘉祥县| 沾化县| 丘北县| 成都市| 西峡县| 平乐县| 长泰县| 宜黄县| 建宁县| 铜山县| 永登县| 九龙坡区| 双峰县| 宝应县| 城固县| 门头沟区| 安国市| 綦江县| 滦南县| 项城市| 克拉玛依市| 灵璧县| 保靖县| 务川| 赤峰市| 马山县| 柯坪县| 黄浦区| 高雄县| 建湖县| 武鸣县| 新安县| 江津市| 福清市| 四子王旗| 永城市| 普兰店市| 始兴县| 海城市|